期刊文献+

大鼠Nogo受体基因RNA干扰慢病毒载体的构建与鉴定 被引量:2

Construction and identification of a recombinant lentivirus harboring RNAi targeting rat Nogo receptor gene
下载PDF
导出
摘要 目的:构建大鼠Nogo受体(Nogoreceptor,NgR)基因RNA干扰慢病毒表达载体,并观察其对293T细胞感染效率。方法:应用基因工程技术,首先构建携带目的基因siNgR199的慢病毒穿梭质粒表达载体,然后使用慢病毒包装质粒混合物和构建好的慢病毒穿梭质粒共转染293T细胞,转染48h后收集上清离心过滤后冰浴保存,最后进行病毒滴度测定,与标准病毒液分别感染293T细胞,按MOI值分为5个梯度:1、3、5、10、20,以确定病毒滴度及适合感染的MOI值。其中采用PCR方法对重组载体进行鉴定,利用绿色荧光蛋白作为报告基因,对病毒滴度和感染效率进行检测。结果:酶切鉴定及PCR结果与病毒载体的预期结果一致,病毒滴度达1×108ifu/m1,适合感染的MOI值为3。结论:应用基因工程技术,成功构建了大鼠siNgR199慢病毒表达载体,为应用于治疗脊髓损伤后轴突再生创造了条件。 Objectire:To construct a recombinant lentivirus harboring RNAi sequence targeting rat nogo receptor gene and to observe its infection efficiency of 293T cells. Methods: Lentivirus shuttle plasmid containing siNgR199 cDNA was constructed by gene engineering and was used to transfect 293T cells in the presence of packaging plasmids. Forty-eight hours later the supernatant was collected and the titer of virus was determined. The recombinant lentivirus and the standard lentivirus were used to transfect 293T cells at 1 MOI,3 MOI,5 MOI, 10 MOI and 20 MOI. Polymerase chain reaction (PCR) was used to detect the recombinant vectort enhanced green fluorescent protein (EGFP) expression was used to determine the titer and the infection rate of the recombinant lentivirus under fluorescent microscope. Results: Restriction endonuclease and PCR analysis confirmed that the siNgR199 cDNA was successfully inserted into the lentivirus vector. The titer of the recombinant lentivirus harboring siNgR199 was 1 ×10^8 ifu/ml and the best MOI was 3. Conclusion- The recombinant lentivirus containing siNgR199 gene has been successfully constructed, which lays a foundation for future axon regeneration in treatment of spinal cord injury.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2007年第1期40-43,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30471757) 长江学者和创新团队发展计划 上海市医学领军人才项目~~
关键词 慢病毒 NOGO受体 RNA干扰 lentivirus, Nogo receptor RNA interfering
  • 相关文献

参考文献6

  • 1Woolf C J,Bloechlinger S.It takes morethan two to Nogo[J].Science,2002,297:1132-1134. 被引量:1
  • 2张涛,袁文,刘百峰,曹莉,肖林,陈公星.siRNA干扰大鼠神经元Nogo受体mRNA表达的时程研究[J].中国脊柱脊髓杂志,2005,15(10):588-591. 被引量:13
  • 3Myers J W,Jones J T,Meyer T,et a1.Recombinant Dicer efficiently converts large dsRNAsinto siRNAs suitable for gene silencing[J].Nat Biotechno1,2003,21:324-328. 被引量:1
  • 4Karolewski B A,Watson D J,Parente M K,et al.Comparison of transfection conditions for alentivirus vector produced in large volumes[J].Hum Gene Ther,2003,14:1287-1296. 被引量:1
  • 5Sinn P L,Sauter S L,McCray P B Jr.Gene therapy progress and prospects:development ofimproved lentiviral and retroviral vectors-design,biosafety,and production[J].GeneTher,2005,12:1089-1098. 被引量:1
  • 6Romano G.Current development of lentiviral-mediated gene transfer[J].Drug NewsPerspect,2005,18:128-134. 被引量:1

二级参考文献6

  • 1Woolf C J, Bloechlinger S. It takes more than two to Nogo[J].Science, 2002,297 (5584 ): 1132-1134. 被引量:1
  • 2Yu JY,DeRuiter SL,Turner DL. RNA interference by expression of short interferencing RNAs and hairpin RNAs in mammalian cells [J].Pror Natl Acad Sci USA,2002,99 (9):6047-6052. 被引量:1
  • 3Krichevsky AM,Kosik KS. RNAi functions in cultured mammalian neurons [J].Proc Natl Acad Sci USA,2002,99(18):11926-11929. 被引量:1
  • 4Elbashir SM,Lendeckel W,Tuschl T. RNA interference is mediated by 21- and 22 -nucleotide RNAs[J].Genes Dev,2001,15(2): 188-200. 被引量:1
  • 5David S,Lacroix S. Molecular approaches to spinal cord repair [J].Annu Rev Neurosci,2003,26:411-440. 被引量:1
  • 6Damm-Welk C,Fuchs U,Wossmann W, et al. Targeting oncogenic fusion genes in leukemias and lymphomas by RNA interference[J].Semin Cancer Biol,2003,13(4) :283-292. 被引量:1

共引文献12

同被引文献21

  • 1张涛,袁文,刘百峰,曹莉,肖林,陈公星.siRNA干扰大鼠神经元Nogo受体mRNA表达的时程研究[J].中国脊柱脊髓杂志,2005,15(10):588-591. 被引量:13
  • 2Woolf CJ,Bloechlinger S.Neuroscience.It takes more than two to Nogo.Science,2002,297:1132-1134. 被引量:1
  • 3Anson DS.The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.Genet Vaccines Ther,2004,2:9. 被引量:1
  • 4Karolewski BA,Watson DJ,Parente MK,et al.Comparison of transfection conditions for a lentivirus vector produced in large volumes.Hum Gene T her,2003,14:1287-1296. 被引量:1
  • 5Hommel JD,Sears RM,Georgescu D,et al.Local gene knock down in the brain using viral-mediated RNA interference.Nat Med,2003,9:1539-1544. 被引量:1
  • 6Dom G,Patel S,Wotherspoon G,et al.siRNA relieves chronic neuropathic pain.Nucleic Acids Res,2004,32:e49. 被引量:1
  • 7McCaffrey AP,Meuse L,Pham TT,et al.RNA interference in adult mice.Nature,2002,418:38-39. 被引量:1
  • 8Giladi H,Ketzinel-Gilad M,Rivkin L,et al.Small interfering RNA inhibits hepatitis B virus replication in mice.Mol Ther,2003,8:769-776. 被引量:1
  • 9Song E,Lee SK,Wang J,et al.RNA interference targepting Fas protects mice from fulminant hepatitis.Nat Med,2003,9:347-351. 被引量:1
  • 10Kobayashi N,Matsui Y,Kawase A,et al.Vector-based in vivo RNA interference:dose-and time-dependent suppression of transgene expression.J Pharmacol Exp Ther,2004,308:688-693. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部